Who traded when
BuySaleAnalyst consensus: bullish or bearish?
Analysts rate Gan & Lee Pharmaceuticals. Strong Buy (bullish), based on 2 analysts. Average price target: CN¥83.50.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 5,000 shares@ CN¥593.16264.8% of flowA股XSHGSSE:273000001641019780
- 20,000 shares@ CN¥588.076523.3% of flowA股XSHGSSE:273000001641019740
- 10,000 shares@ CN¥574.5069.8% of flowA股XSHGSSE:273000001609500830
- 5,000 shares@ CN¥569.58235.4% of flowA股XSHGSSE:273000001604774720
- 5,000 shares@ CN¥565.3009100.0% of flowA股XSHGSSE:273000001604774800
- 30,000 shares@ CN¥566.361133.8% of flowA股XSHGSSE:273000001598880600
- 50,000 shares@ CN¥560.599745.1% of flowA股XSHGSSE:273000001585690370
- 17,000 shares@ CN¥569.642881.8% of flowA股XSHGSSE:273000001585690050
- 70,000 shares@ CN¥561.48176.7% of flowA股XSHGSSE:273000001585690180
- 26,000 shares@ CN¥545.3987100.0% of flowA股XSHGSSE:273000001575369920
- 10,000 shares@ CN¥551.151716.1% of flowA股XSHGSSE:273000001449606660
- 3,000 shares@ CN¥555.809413.7% of flowA股XSHGSSE:273000001449606720
- 1,000 shares@ CN¥549.30984.5% of flowA股XSHGSSE:273000001442647780
- 500 shares@ CN¥547.6586100.0% of flowA股XSHGSSE:273000001434740670
14 of 14 declarations
About Gan & Lee Pharmaceuticals.
Gan & Lee Pharmaceuticals. (甘李药业), a Chinese health care and pharma company valued at CNY 41.8 billion and 42.1% held by its insiders, has a record that fits in one month: 14 filings published between September 1, 2026 and September 30, 2026, all sales, worth EUR 2.4 million with a median of EUR 95,145. They are also all of the filings of the last twelve months.
The largest amounts sit between September 23, 2026 and September 24, 2026: EUR 669,200 for 邢程 (高级管理人员) and EUR 477,250 for 宋维强 (董事,高级管理人员) on September 23, then EUR 290,847 for 宋维强 on September 24. 宋维强 signs 6 filings, 李智 (高级管理人员) 3 and 邢程 2; 陈伟 (董事,高级管理人员) and 苑字飞 (高级管理人员) one each.
Read moreShow less
Six people appear in the record, with no purchase at all, and the median shows that most sales stay far below the maximum of EUR 669,200. Filings are published on the very day of the trade in median.
